Su idioma
Su idioma
Fucithalmic®

Look again at how you treat bacterial conjunctivitis or blepharitis.

About Fucithalmic

Fucithalmic (fusidic acid) is indicated for the topical treatment of bacterial conjunctivitis and blepharitis where the microbiological organism/pathogen is known to be sensitive to the antibiotic1

Over 30 years proven efficacy in treating bacterial conjunctivitis2

Sustained targeted action against the most common bacteria causing eye infections, e.g. Staphylococcus aureus and Streptococcus pneumoniae1,3–6

Treats blepharitis, which is predominantly caused by staphylococcal organisms1, 7

A well tolerated treatment with mild and transient adverse events, such as transient stinging and/or burning sensation8–10

A convenient twice-daily dosing regimen1,11

PRESCRIBING INFORMATION & ADVERSE EVENT REPORTING BOX
Learn More

REFERENCES:

  1. ADVANZ PHARMA. Fucithalmic®  10mg/g eye drops. Finland Summary of product characteristics. Last updated April 2018.
  2. Fucithalmic®  Product Monograph. Leo Pharma Inc. 2008.
  3. Care of the Patient with Conjunctivitis. Optometric Clinical Practice Guideline. American Optometric Association, 2002. Available at:
    https://www.aoa.org/documents/optometrists/CPG-11.pdf Last accessed May 2019
  4. Orden Martínez B et al. An Pediatr (Barc) 2004; 61:32–6.
  5. Conjunctivitis (Pink Eye). For Clinicians. Centers for Disease Control and Prevention. Available at:
    https://www.cdc.gov/conjunctivitis/clinical.html Last accessed May 2019
  7. Epling J. BMJ Clin Evidence 2012 Feb 20;2012. pii 0704.
  8. Seal DV. Placebo controlled trial of fusidic acid gel and oxytetracycline for recurrent blepharitis and rosacea. Br J Ophthalmol. 1995 Jan;79(1):42-5.
  9. Wall AR et al. J Clin Res 1998;1:316–25.
  10. Carr WD. J Clin Res 1998;1:403–11.
  11. Dirdal M. Acta Ophthalmol (Copenh) 1987;65:129–33.
  12. Jackson WB et al. Can J Ophthalmol 2002;37:228–37.